In addition, we explored the mechanistic role of E2F7−EZH2 axis in AKT/mTOR activation, and the results suggested that E2F7 promoted glioblastoma progression via EZH2-mediated PTEN/AKT pathway. The gene discussed is EZH2; the disease is glioblastoma.